JSLLBSEJeena Sikho Lifecare LtdHighNeutral
Announced Sat, 30 May · 19:05 IST

Re-Appointment of M/s Forviz Mazars LLP as the Internal Auditor of the Company for financial year 2026-27.

Revenue Growth 20pctPat Growth 25pctResults View source PDF

JSLL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-5.4%1-day move
₹624.00
prior close
₹570.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-6.1-5.6-6.3-13.7-5.4+12.2+4.6+0.8-1.4-6.4-1.5-6.1
Up moveDown movePending
AI summary

Jeena Sikho Lifecare Limited reported strong audited financial results for FY 2026. Standalone revenue from operations grew 70.8% to Rs. 80,134.64 lakhs from Rs. 46,907.19 lakhs in FY 2025. Profit after tax surged 177.9% to Rs. 22,217.57 lakhs from Rs. 7,994.33 lakhs. Basic EPS improved to Rs. 17.87 from Rs. 6.43. The Board also recommended a final dividend of Rs. 4.50 per equity share (face value Rs. 2) for FY 2025-26, subject to shareholder approval. Statutory auditors Walker Chandiok & Co LLP issued unmodified (clean) audit opinions on both standalone and consolidated results. The company reappointed Forvis Mazars LLP as internal auditor for FY 2026-27 based on the Audit Committee's recommendation.

Likely market impact

The company delivered exceptional growth with PAT nearly tripling year-on-year, indicating strong operational performance. The clean audit opinion and dividend recommendation are positive signals for shareholders. The internal auditor reappointment maintains governance continuity.